The pathogenesis of mesothelioma is driven by a dysregulated translatome
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The pathogenesis of mesothelioma is driven by a dysregulated translatome
Authors
Keywords
-
Journal
Nature Communications
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-08-13
DOI
10.1038/s41467-021-25173-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunotherapy for mesothelioma: a critical review of current clinical trials and future perspectives
- (2020) Steven G. Gray et al. Translational Lung Cancer Research
- Repression of the Type I Interferon Pathway Underlies MYC- and KRAS-Dependent Evasion of NK and B Cells in Pancreatic Ductal Adenocarcinoma
- (2020) Nathiya Muthalagu et al. Cancer Discovery
- Whole-genome sequencing of human malignant mesothelioma tumours and cell lines
- (2019) Harald Oey et al. CARCINOGENESIS
- OUP accepted manuscript
- (2018) ANNALS OF ONCOLOGY
- Post-transcriptional control of stress responses in cancer
- (2018) Robert F Harvey et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma
- (2018) Tatsuhiro Sato et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Structure-based Design of Pyridone–Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition
- (2018) Siegfried H. Reich et al. JOURNAL OF MEDICINAL CHEMISTRY
- Progress in the Management of Malignant Pleural Mesothelioma in 2017
- (2018) Amanda J. McCambridge et al. Journal of Thoracic Oncology
- Progress and challenges in Mesothelioma: From bench to bedside
- (2018) Kevin G. Blyth et al. RESPIRATORY MEDICINE
- Mutational Profiling of Malignant Mesothelioma Revealed Potential Therapeutic Targets in EGFR and NRAS
- (2018) Jeong Eun Kim et al. Translational Oncology
- Eukaryotic Translation Initiation Factor 4 Gamma 1 (eIF4G1) is upregulated during Prostate cancer progression and modulates cell growth and metastasis
- (2018) Praveen Kumar Jaiswal et al. Scientific Reports
- Combined inhibition of PI3Kβ and mTOR inhibits growth of PTEN null tumours
- (2018) James T Lynch et al. MOLECULAR CANCER THERAPEUTICS
- GenBank
- (2018) Eric W Sayers et al. NUCLEIC ACIDS RESEARCH
- BAP1 regulates different mechanisms of cell death
- (2018) El Bachir Affar et al. Cell Death & Disease
- Integrative Molecular Characterization of Malignant Pleural Mesothelioma
- (2018) Julija Hmeljak et al. Cancer Discovery
- mTOR Controls Mitochondrial Dynamics and Cell Survival via MTFP1
- (2017) Masahiro Morita et al. MOLECULAR CELL
- RefSeq: an update on prokaryotic genome annotation and curation
- (2017) Daniel H Haft et al. NUCLEIC ACIDS RESEARCH
- An improved analysis methodology for translational profiling by microarray
- (2017) Thomas Sbarrato et al. RNA
- mTORC2 Signaling Drives the Development and Progression of Pancreatic Cancer
- (2016) David R. Driscoll et al. CANCER RESEARCH
- Bap1 Is a Bona Fide Tumor Suppressor: Genetic Evidence from Mouse Models Carrying Heterozygous Germline Bap1 Mutations
- (2016) Y. Kadariya et al. CANCER RESEARCH
- Molecular profiling reveals primary mesothelioma cell lines recapitulate human disease
- (2016) T Chernova et al. CELL DEATH AND DIFFERENTIATION
- nanoCAGE reveals 5′ UTR features that define specific modes of translation of functionally related MTOR-sensitive mRNAs
- (2016) Valentina Gandin et al. GENOME RESEARCH
- Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations
- (2016) Raphael Bueno et al. NATURE GENETICS
- A ribosome-related signature in peripheral blood CLL B cells is linked to reduced survival following treatment
- (2016) T Sbarrato et al. Cell Death & Disease
- Targeting the eIF4F Translation Initiation Complex: A Critical Nexus for Cancer Development
- (2015) J. Pelletier et al. CANCER RESEARCH
- The Utilization of Extracellular Proteins as Nutrients Is Suppressed by mTORC1
- (2015) Wilhelm Palm et al. CELL
- Translational Tolerance of Mitochondrial Genes to Metabolic Energy Stress Involves TISU and eIF1-eIF4GI Cooperation in Start Codon Selection
- (2015) Hadar Sinvani et al. Cell Metabolism
- First-in-Human Pharmacokinetic and Pharmacodynamic Study of the Dual m-TORC 1/2 Inhibitor AZD2014
- (2015) B. Basu et al. CLINICAL CANCER RESEARCH
- SWOG S0722: Phase II Study of mTOR Inhibitor Everolimus (RAD001) in Advanced Malignant Pleural Mesothelioma (MPM)
- (2015) Sai-Hong Ignatius Ou et al. Journal of Thoracic Oncology
- AZD2014, an Inhibitor of mTORC1 and mTORC2, Is Highly Effective in ER+ Breast Cancer When Administered Using Intermittent or Continuous Schedules
- (2015) S. M. Guichard et al. MOLECULAR CANCER THERAPEUTICS
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma
- (2015) A Napolitano et al. ONCOGENE
- The malignant phenotype in breast cancer is driven by eIF4A1-mediated changes in the translational landscape
- (2015) A Modelska et al. Cell Death & Disease
- Expression and activity of eIF6 trigger Malignant Pleural Mesothelioma growth in vivo
- (2015) Annarita Miluzio et al. Oncotarget
- Suppression of Feedback Loops Mediated by PI3K/mTOR Induces Multiple Overactivation of Compensatory Pathways: An Unintended Consequence Leading to Drug Resistance
- (2014) E. Rozengurt et al. MOLECULAR CANCER THERAPEUTICS
- Optimization of potent and selective dual mTORC1 and mTORC2 inhibitors: The discovery of AZD8055 and AZD2014
- (2013) Kurt G. Pike et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Tumor Suppressor Alterations Cooperate to Drive Aggressive Mesotheliomas with Enriched Cancer Stem Cells via a p53-miR-34a-c-Met Axis
- (2013) C. W. Menges et al. CANCER RESEARCH
- mTORC1 Controls Mitochondrial Activity and Biogenesis through 4E-BP-Dependent Translational Regulation
- (2013) Masahiro Morita et al. Cell Metabolism
- A role for eukaryotic initiation factor 4B overexpression in the pathogenesis of diffuse large B-cell lymphoma
- (2013) E Horvilleur et al. LEUKEMIA
- The function, mechanisms, and role of the genes PTEN and TP53 and the effects of asbestos in the development of malignant mesothelioma: a review focused on the genes' molecular mechanisms
- (2013) Leonardo Vinícius Monteiro de Assis et al. TUMOR BIOLOGY
- Regulation of mTOR Complex 2 Signaling in Neurofibromatosis 2-Deficient Target Cell Types
- (2012) M. F. James et al. MOLECULAR CANCER RESEARCH
- A unifying model for mTORC1-mediated regulation of mRNA translation
- (2012) Carson C. Thoreen et al. NATURE
- Mortality from asbestosis and mesothelioma in Britain by birth cohort
- (2012) A. Darnton et al. OCCUPATIONAL MEDICINE-OXFORD
- The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma
- (2011) Matthew Bott et al. NATURE GENETICS
- BioProfiling.de: analytical web portal for high-throughput cell biology
- (2011) A. V. Antonov NUCLEIC ACIDS RESEARCH
- Unique translation initiation of mRNAs-containing TISU element
- (2011) Rofa Elfakess et al. NUCLEIC ACIDS RESEARCH
- Sensitivity of Global Translation to mTOR Inhibition in REN Cells Depends on the Equilibrium between eIF4E and 4E-BP1
- (2011) Stefano Grosso et al. PLoS One
- Projection of mesothelioma mortality in Britain using Bayesian methods
- (2010) E Tan et al. BRITISH JOURNAL OF CANCER
- The ARF Tumor Suppressor Controls Ribosome Biogenesis by Regulating the RNA Polymerase I Transcription Factor TTF-I
- (2010) Frédéric Lessard et al. MOLECULAR CELL
- Occupational, domestic and environmental mesothelioma risks in the British population: a case–control study
- (2009) C Rake et al. BRITISH JOURNAL OF CANCER
- An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1
- (2009) Carson C. Thoreen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dysregulation of protein synthesis and disease
- (2009) John PC Le Quesne et al. JOURNAL OF PATHOLOGY
- Loss of the Tumor Suppressor Gene NF2, Encoding Merlin, Constitutively Activates Integrin-Dependent mTORC1 Signaling
- (2009) M. A. Lopez-Lago et al. MOLECULAR AND CELLULAR BIOLOGY
- NF2/Merlin Is a Novel Negative Regulator of mTOR Complex 1, and Activation of mTORC1 Is Associated with Meningioma and Schwannoma Growth
- (2009) M. F. James et al. MOLECULAR AND CELLULAR BIOLOGY
- SUnSET, a nonradioactive method to monitor protein synthesis
- (2009) Enrico K Schmidt et al. NATURE METHODS
- Upstream open reading frames cause widespread reduction of protein expression and are polymorphic among humans
- (2009) S. E. Calvo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
- (2009) Morris E Feldman et al. PLOS BIOLOGY
- A Conditional Mouse Model for Malignant Mesothelioma
- (2008) Johan Jongsma et al. CANCER CELL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now